SLC transporters as therapeutic targets: emerging opportunities

L Lin, SW Yee, RB Kim, KM Giacomini - Nature reviews Drug discovery, 2015 - nature.com
Solute carrier (SLC) transporters—a family of more than 300 membrane-bound proteins that
facilitate the transport of a wide array of substrates across biological membranes—have …

[HTML][HTML] A call for systematic research on solute carriers

A Cesar-Razquin, B Snijder, T Frappier-Brinton… - Cell, 2015 - cell.com
Solute carrier (SLC) membrane transport proteins control essential physiological functions,
including nutrient uptake, ion transport, and waste removal. SLCs interact with several …

Post-translational modifications of transporters

LC Czuba, KM Hillgren, PW Swaan - Pharmacology & therapeutics, 2018 - Elsevier
Drug transporter proteins are critical to the distribution of a wide range of endogenous
compounds and xenobiotics such as hormones, bile acids, peptides, lipids, sugars, and …

SLC transporters: structure, function, and drug discovery

C Colas, PMU Ung, A Schlessinger - Medchemcomm, 2016 - pubs.rsc.org
The human solute carrier (SLC) transporters are important targets for drug development.
Structure-based drug discovery for SLC transporters requires the description of their …

[HTML][HTML] How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion

DB Kell, SG Oliver - Frontiers in pharmacology, 2014 - frontiersin.org
One approach to experimental science involves creating hypotheses, then testing them by
varying one or more independent variables, and assessing the effects of this variation on the …

The solute carrier SLC15A4 is required for optimal trafficking of nucleic acid–sensing TLRs and ligands to endolysosomes

I Rimann, R Gonzalez-Quintial… - Proceedings of the …, 2022 - National Acad Sciences
A function-impairing mutation (feeble) or genomic deletion of SLC15A4 abolishes responses
of nucleic acid–sensing endosomal toll-like receptors (TLRs) and significantly reduces …

[HTML][HTML] Cellular models and in vitro assays for the screening of modulators of P-gp, MRP1 and BCRP

M Gameiro, R Silva, C Rocha-Pereira, H Carmo… - Molecules, 2017 - mdpi.com
Adenosine triphosphate (ATP)-binding cassette (ABC) transporters are highly expressed in
tumor cells, as well as in organs involved in absorption and secretion processes, mediating …

Bypassing P‐glycoprotein drug efflux mechanisms: possible applications in Pharmacoresistant schizophrenia therapy

FG Hoosain, YE Choonara, LK Tomar… - BioMed research …, 2015 - Wiley Online Library
The efficient noninvasive treatment of neurodegenerative disorders is often constrained by
reduced permeation of therapeutic agents into the central nervous system (CNS). A vast …

Models for drug absorption from the small intestine: where are we and where are we going?

PA Billat, E Roger, S Faure, F Lagarce - Drug discovery today, 2017 - Elsevier
Highlights•It is of primary importance to obtain relevant models in drug
discovery.•Physiology and biology of the oral route is complex to model.•In silico models …

OCTN: a small transporter subfamily with great relevance to human pathophysiology, drug discovery, and diagnostics

L Pochini, M Galluccio, M Scalise… - … the Science of Drug …, 2019 - journals.sagepub.com
OCTN is a small subfamily of membrane transport proteins that belongs to the larger SLC22
family. Two of the three members of the subfamily, namely, OCTN2 and OCTN1, are present …